Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

MindMetre research note highlights exposure of oncology nurses to harmful effects of cytotoxic drugs

Independent research organisation MindMetre, which regularly addresses patient and healthcare worker safety across Europe, has examined evidence from qualitative interviews, clinical research and case studies that harm is being sustained by chemotherapy nurses in UK NHS Trusts as a result of exposure to hazardous cytotoxic drugs.

22 Mar 2017

Dana-Farber and Lifespan enter into strategic alliance to advance cancer treatment and research

Dana-Farber Cancer Institute and Lifespan leadership are creating a strategic alliance to advance cancer treatment and research.

22 Mar 2017

Vanderbilt study compares side effects, outcomes of prostate cancer treatments with active surveillance

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association

21 Mar 2017

New study correlates 80 cancer-related gene mutations with 34 AML subgroups

A large, new study of adults with acute myeloid leukemia (AML) correlates 80 cancer-related gene mutations with five subtypes of AML, which are defined by the presence of specific chromosomal abnormalities. The findings might help guide mutation testing and treatment decisions in the future.

21 Mar 2017

Study finds little clinical benefit in placing nasogastric tube for treating upper GI bleeds

For many of the millions of patients treated annually in hospitals for upper gastrointestinal (GI) bleeding, there is little value in placing a nasogastric (NG) tube in patients to determine the source of that bleeding or size of a lesion, report investigators in an article published online ahead of print on January 9, 2017 by the Journal of Investigative Medicine.

20 Mar 2017

Reirradiation using proton therapy offers new hope for patients with recurrent lung cancer

A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment. In the largest analysis to date of reirradiation using intensity-modulated proton therapy for lung and other thoracic tumors, more than three-fourths of patients were free from local recurrence at one year following retreatment, and fewer than one in ten patients experienced severe side effects.

17 Mar 2017

Research shows SBRT as viable curative option for older lung cancer patients

Patients in their 80s and 90s who have early stage lung cancer but cannot undergo an operation can be treated safely and effectively with stereotactic body radiation therapy (SBRT), according to research presented today at the 2017 Multidisciplinary Thoracic Cancers Symposium.

17 Mar 2017

Study reveals prevalence of racial disparities in treatment, outcomes of early stage NSCLC patients

Analysis of the largest American cancer database indicates that racial disparities persist in the treatment and outcomes of patients diagnosed with stage I non-small cell lung cancer (NSCLC).

17 Mar 2017

Genetic mutations underlying treatment resistance in NSCLC more dynamic than previously thought

The genetic mutations underlying treatment resistance in non-small cell lung cancer (NSCLC) are more complex and dynamic than previously thought.

17 Mar 2017

Combination approach holds potential for treating lung cancer patients

An emerging approach for cancer treatment seeks to combine radiation therapy with immune checkpoint inhibitors to more effectively control tumors in the chest with an acceptable risk of severe treatment-related side effects.

17 Mar 2017

Biomarker blood test detects recurrences of lung cancer before conventional imaging methods

Results from a prospective clinical trial showed that a blood test looking at specific biomarkers was able to detect recurrences of lung cancer an average of six months before conventional imaging methods found evidence of recurrence.

17 Mar 2017

Increased palliative care consultation for advanced cancer patients leads to better outcomes

A recent study demonstrated that increased palliative care consultations for patients with advanced cancers is associated with substantial impact on 30-day readmission, administration of chemotherapy following discharge, hospice referral, and use of support services following discharge.

17 Mar 2017

Intensity modulated proton therapy shows early promise for treatment of recurrent lung cancer

An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy, has shown early promise for the treatment of recurrent lung cancer, according to new research from The University of Texas MD Anderson Cancer Center.

17 Mar 2017

Palliative care consults for advanced cancer patients linked to improvement in multiple quality measures

Cancer patients admitted to the hospital with advanced stages of disease who were referred early to palliative care had decreased health care utilization and increased use of support services following discharge, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai. c

17 Mar 2017

ASCO issues first clinical practice guideline on HPV vaccination for cervical cancer prevention

The American Society of Clinical Oncology (ASCO) today issued a clinical practice guideline on human papillomavirus (HPV) vaccination for the prevention of cervical cancer.

17 Mar 2017

The Sohn Conference Foundation funds research to advance understanding of how pediatric cancer metastasizes

The Sohn Conference Foundation today unveiled the Sohn Collaborative for Liquid Biopsy at Weill Cornell Medicine to develop a blood test that will predict how cancer spreads in both children and adults.

17 Mar 2017

Yale study identifies racial and ethnic disparities in Oncotype DX testing for women with breast cancer

In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive (HR+) breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.

17 Mar 2017

Roswell Park-led study shows benefits of ‘one and done’ SBRT treatment approach for NSCLC patients

New research led by a radiation oncologist at Roswell Park Cancer Institute indicates that less may be more when it comes to some forms of radiation therapy for cancer.

17 Mar 2017

UT Southwestern researchers develop computer model to predict most deadly lung cancers

After evaluating more than 900 differences in the shape and structure of cancer cells, UT Southwestern Medical Center researchers developed a computer model able to predict the most deadly lung cancers based on a fraction of those features.

16 Mar 2017

Penn studies provide new understanding of lung cancer progression and prevention

Treating the brain with a preventative course of radiation may help Small Cell Lung Cancer (SCLC) patients - whose tumors often spread to their brain -- live longer, according to a new study from researchers in the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.

16 Mar 2017

Oncology News and Research

Further Reading

MindMetre research note highlights exposure of oncology nurses to harmful effects of cytotoxic drugs

Dana-Farber and Lifespan enter into strategic alliance to advance cancer treatment and research

Vanderbilt study compares side effects, outcomes of prostate cancer treatments with active surveillance

New study correlates 80 cancer-related gene mutations with 34 AML subgroups

Study finds little clinical benefit in placing nasogastric tube for treating upper GI bleeds

Reirradiation using proton therapy offers new hope for patients with recurrent lung cancer

Research shows SBRT as viable curative option for older lung cancer patients

Study reveals prevalence of racial disparities in treatment, outcomes of early stage NSCLC patients

Genetic mutations underlying treatment resistance in NSCLC more dynamic than previously thought

Combination approach holds potential for treating lung cancer patients

Biomarker blood test detects recurrences of lung cancer before conventional imaging methods

Increased palliative care consultation for advanced cancer patients leads to better outcomes

Intensity modulated proton therapy shows early promise for treatment of recurrent lung cancer

Palliative care consults for advanced cancer patients linked to improvement in multiple quality measures

ASCO issues first clinical practice guideline on HPV vaccination for cervical cancer prevention

The Sohn Conference Foundation funds research to advance understanding of how pediatric cancer metastasizes

Yale study identifies racial and ethnic disparities in Oncotype DX testing for women with breast cancer

Roswell Park-led study shows benefits of ‘one and done’ SBRT treatment approach for NSCLC patients

UT Southwestern researchers develop computer model to predict most deadly lung cancers

Penn studies provide new understanding of lung cancer progression and prevention

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News